Sunday, Sep 20, 2020 | Last Update : 10:40 PM IST

180th Day Of Lockdown

Maharashtra118801585793332216 Andhra Pradesh6177765307115302 Tamil Nadu5364774812738751 Karnataka5113454048417922 Uttar Pradesh3362942632884771 Delhi2347011981034877 West Bengal2155801870614183 Telangana1713061397001033 Odisha167161133466722 Bihar164224149722855 Assam150349121610528 Kerala12221687341490 Gujarat119088999083271 Rajasthan109088906851293 Haryana103773816901069 Madhya Pradesh97906743981877 Punjab90032658182646 Chhatisgarh7777541111628 Jharkhand6710052807590 Jammu and Kashmir5971138521951 Uttarakhand3713924810460 Goa2678320844327 Puducherry2142816253431 Tripura2069612956222 Himachal Pradesh11190691997 Chandigarh92566062106 Manipur8430653951 Arunachal Pradesh6851496713 Nagaland5306407910 Meghalaya4356234232 Sikkim2119178923 Mizoram15069490
  Life   Health  26 Dec 2019  Artificial intelligence can now track down blood cancer

Artificial intelligence can now track down blood cancer

ANI
Published : Dec 26, 2019, 11:12 am IST
Updated : Dec 26, 2019, 11:12 am IST

Artificial intelligence tracks down acute myeloid leukaemia.

The transcriptome holds important information about the condition of cells. (Photo: ANI)
 The transcriptome holds important information about the condition of cells. (Photo: ANI)

Washington: Tracking down acute myeloid leukaemia (AML), researchers have proved that artificial intelligence can detect forms of blood cancer. The study was conducted by the researchers of the German Center for Neurodegenerative Diseases (DZNE) and was published in the recent edition of the iScience journal.

The approach used by researchers revolved around the gene activity analysis of cells that are present in the blood. This approach could support conventional diagnostics and accelerate therapy of the disease.

 

"Some studies have been carried out on this topic and the results are available through. Thus, there is an enormous data pool. We have collected virtually everything that is currently available," said Professor Joachim Schultze who led the group of researchers of the study.

'Transcriptome' which is a fingerprint of gene activity was the centre of focus of the researchers. In all cells, only certain genes are actually 'switched on' which gets reflected in their profiles of gene activity. Such types of data that are derived from cells present in blood samples and spanning thousands of genes were analysed in the study.

"The transcriptome holds important information about the condition of cells. However, classical diagnostics is based on different data. We, therefore, wanted to find out what an analysis of the transcriptome can achieve using artificial intelligence, that is to say, trainable algorithms," Schultze said.

 

"In the long term, we intend to apply this approach to further topics, in particular in the field of dementia," he added. The study revolved around AML which without adequate treatment leads to death within weeks. Researchers concluded that the method of tracking AML using Artificial Intelligence when putting into the application, could support conventional diagnostics and help save costs.

"In principle, a blood sample taken by the family doctor and sent to a laboratory for analysis could suffice. I guess that the cost would be less than 50 euros. However, we have not yet developed a workable test. We have only shown that the approach works in principle. So we have laid the groundwork for developing a test," Schultze said.

 

Classical AML diagnostics includes a variety of methods. The researcher emphasised that the aim of the study is to provide the experts with a tool for diagnosis of the disease.

Tags: cancer, blood cancer, leukaemia